Login / Signup

Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.

Alberto TosettoZahra BadieeMohammad-Reza BaghaipourLuciano BaroncianiJavier BattleErik BerntorpImre BodóUlrich BuddeGiancarlo CastamanJeroen C J EikenboomPeyman EshghiCosimo EttorreAnne GoodeveJenny GoudemandCharles Richard Morris HayHamid HoorfarMehran KarimiBijan KeikhaeiRiitta LassilaFrank W G LeebeekMaria Fernanda Lopez FernandezPier Mannuccio MannucciMaria Gabriella MazzucconiMassimo MorfiniJohannes OldenburgIan PeakeRafael Parra LòpezFlora PeyvandiReinhard SchneppenheimAndreas TiedeGholamreza ToogehMarc TrossaertOmidreza ZekavatEva M K ZetterbergAugusto B Federici
Published in: Journal of thrombosis and haemostasis : JTH (2020)
In the largest cohort of type 3 VWD patients, we were able to describe a distinct clinical phenotype that is associated with the presence of a more severe hemostatic defect.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • atrial fibrillation
  • patient reported outcomes
  • physical activity
  • drug induced